Detalus Advisors, LLC
- SEC CIK
- 0001799677
- Latest filing
- Jul 27, 2026
ABBV holding history
AbbVie Inc. in every 13F filed by Detalus Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings
- Shares (Q2 2026)
- 14,381
- Value
- $3.62M
- % of portfolio
- 0.7%
- Quarters held
- 21
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 14,381 | $3.62M | 0.7% | −275−1.9% | Reduced | Holders |
| Q1 2026 | 14,656 | $3.19M | 0.7% | −63−0.4% | Reduced | Holders |
| Q4 2025 | 14,719 | $3.36M | 0.8% | −70.0% | Reduced | Holders |
| Q3 2025 | 14,726 | $3.41M | 0.9% | +25+0.2% | Added | Holders |
| Q2 2025 | 14,701 | $2.73M | 0.8% | +20.0% | Added | Holders |
| Q1 2025 | 14,699 | $3.08M | 1.0% | +65+0.4% | Added | Holders |
| Q4 2024 | 14,634 | $2.60M | 0.9% | +36+0.2% | Added | Holders |
| Q3 2024 | 14,598 | $2.88M | 1.0% | +44+0.3% | Added | Holders |
| Q2 2024 | 14,554 | $2.50M | 0.9% | −1,451−9.1% | Reduced | Holders |
| Q1 2024 | 16,005 | $2.91M | 1.0% | −124−0.8% | Reduced | Holders |
| Q4 2023 | 16,129 | $2.50M | 1.0% | −400−2.4% | Reduced | Holders |
| Q3 2023 | 16,529 | $2.46M | 1.2% | −200−1.2% | Reduced | Holders |
| Q2 2023 | 16,729 | $2.25M | 1.0% | +224+1.4% | Added | Holders |
| Q1 2023 | 16,505 | $2.63M | 1.3% | −994−5.7% | Reduced | Holders |
| Q4 2022 | 17,499 | $2.83M | 1.4% | +13,785+371.2% | Added | Holders |
| Q3 2022 | 3,714 | $498.0K | 0.3% | −100−2.6% | Reduced | Holders |
| Q2 2022 | 3,814 | $584.0K | 0.3% | 00.0% | Unchanged | Holders |
| Q1 2022 | 3,814 | $618.0K | 0.3% | −2,400−38.6% | Reduced | Holders |
| Q4 2021 | 6,214 | $841.0K | 0.4% | −90−1.4% | Reduced | Holders |
| Q3 2021 | 6,304 | $680.0K | 0.3% | +350+5.9% | Added | Holders |
| Q2 2021 | 5,954 | $671.0K | 0.4% | +5,954 | New | Holders |